Primary

Contrary to longstanding precedent, individualism reigns supreme in recent legal decisions over COVID-19.

A state-level debate over model lesson plans echoes a national battle over teaching racial justice.

Scholar explains why the DEA—not FDA—has power over the classification of potentially addictive substances.

Academics argue that city authorities could cooperate with tech companies to align their values.

A new ACUS recommendation emphasizes how agencies can increase public access to litigation information.

Antitrust has a role in addressing the considerable power social media companies possess over speech.

An ACUS study examines how agency review models differ across agencies.

For-profit colleges target U.S. veterans as a source of federal funds.

ACUS releases a recommendation for how agencies should regulate their rulemaking procedures.

Two scholars argue that immigration adjudication should no longer be afforded Chevron deference.

Bid challenges are effective management tools, not just administrative attacks.

FDA faces mounting pressure from advocacy groups claiming a high chemical content in macaroni and cheese.